Rémi Rosière

1.0k total citations
23 papers, 819 citations indexed

About

Rémi Rosière is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Rémi Rosière has authored 23 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 8 papers in Pharmaceutical Science and 6 papers in Molecular Biology. Recurrent topics in Rémi Rosière's work include Inhalation and Respiratory Drug Delivery (19 papers), Nanoparticle-Based Drug Delivery (6 papers) and Advanced Drug Delivery Systems (6 papers). Rémi Rosière is often cited by papers focused on Inhalation and Respiratory Drug Delivery (19 papers), Nanoparticle-Based Drug Delivery (6 papers) and Advanced Drug Delivery Systems (6 papers). Rémi Rosière collaborates with scholars based in Belgium, France and Czechia. Rémi Rosière's co-authors include Karim Amighi, Nathalie Wauthoz, Véronique Mathieu, Matthias Van Woensel, Florence Lefranc, Steven De Vleeschouwer, Thomas Mathivet, Stefaan Van Gool, Róbert Kiss and Holger Gerhardt and has published in prestigious journals such as Scientific Reports, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Rémi Rosière

23 papers receiving 807 citations

Peers

Countries citing papers authored by Rémi Rosière

Since Specialization

Citations

This map shows the geographic impact of Rémi Rosière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rémi Rosière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rémi Rosière more than expected).

Fields of papers citing papers by Rémi Rosière

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rémi Rosière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rémi Rosière. The network helps show where Rémi Rosière may publish in the future.

Co-authorship network of co-authors of Rémi Rosière

This figure shows the co-authorship network connecting the top 25 collaborators of Rémi Rosière. A scholar is included among the top collaborators of Rémi Rosière based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rémi Rosière. Rémi Rosière is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model 2022 ·Journal of Controlled Release ·Tamara Davenne, (unknown), (unknown), Muriel Moser, Oberdan Léo, Etienne Meylan, Stanislas Goriely, (unknown), Nathalie Wauthoz, Sophie Laurent, Karim Amighi, Rémi Rosière	8
2	Pulmonary and renal tolerance of cisplatin-based regimens combining intravenous and endotracheal routes for lung cancer treatment in mice 2021 ·International Journal of Pharmaceutics ·(unknown), Rémi Rosière, (unknown), (unknown), Myriam Remmelink, Ingrid Langer, Joëlle Nortier, Karim Amighi, Nathalie Wauthoz	5
3	Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of non-small cell lung cancer 2021 ·Biomedicine & Pharmacotherapy ·(unknown), Rémi Rosière, (unknown), (unknown), (unknown), Ingrid Langer, Joëlle Nortier, Myriam Remmelink, Karim Amighi, Nathalie Wauthoz	7
4	The combination of an innovative dry powder for inhalation and a standard cisplatin-based chemotherapy in view of therapeutic intensification against lung tumours 2021 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), Rémi Rosière, (unknown), (unknown), (unknown), Sophie Laurent, Marjorie Vermeersch, Karim Amighi, Nathalie Wauthoz	9
5	Deciphering the chemical instability of sphaeropsidin A under physiological conditions – degradation studies and structural elucidation of the major metabolite 2020 ·Organic & Biomolecular Chemistry ·(unknown), (unknown), Rémi Rosière, Karim Amighi, Lukas Oberer, Kirk R. Gustafson, Dongdong Wang, Antonio Evidente, Lucia Maddau, Marco Masi, André de Villiers, Ivan R. Green, Walter Berger, Alexander Kornienko, Véronique Mathieu, Willem A. L. van Otterlo	1
6	Inhaled cytotoxic chemotherapy: clinical challenges, recent developments, and future prospects 2020 ·Expert Opinion on Drug Delivery ·Nathalie Wauthoz, Rémi Rosière, Karim Amighi	36
7	Pharmacokinetic and Preliminary Toxicity Investigation of an Innovative Controlled-Release Cisplatin Dry Powder Inhalation Formulation in Sheep 2020 ·Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) ·Rémi Rosière, (unknown), (unknown), (unknown), (unknown), Els Meeusen, Karim Amighi, Nathalie Wauthoz, (unknown), Peter R. Byron, Michael Hindle, Joanne Peart, Daniela Traini, Paul M. Young, Stephen J. Farr, Julie Suman, Anthony Watts	1
8	Targeted PEG-poly(glutamic acid) complexes for inhalation protein delivery to the lung 2019 ·Journal of Controlled Release ·(unknown), Huiqi Li, Rémi Rosière, Nathalie Wauthoz, Huw E. L. Williams, (unknown), Cynthia Bosquillon, (unknown), Gemma Keegan, David Coghlan, Giuseppe Mantovani, Snow Stolnik	28
9	The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses 2019 ·Cancers ·Rémi Rosière, Thierry Berghmans, Paul De Vuyst, Karim Amighi, Nathalie Wauthoz	43
10	La chimiothérapie inhalée – partie 2 : clinique et applications potentielles 2018 ·Revue des Maladies Respiratoires ·Rémi Rosière, J. Hureaux, (unknown), Karim Amighi, Nathalie Wauthoz	4
11	La chimiothérapie inhalée – partie 1 : concept et challenges technologiques actuels 2018 ·Revue des Maladies Respiratoires ·Rémi Rosière, J. Hureaux, (unknown), Karim Amighi, Nathalie Wauthoz	8
12	New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation 2018 ·Molecular Pharmaceutics ·Rémi Rosière, Matthias Van Woensel, Michel Gelbcke, Véronique Mathieu, (unknown), Thomas Mathivet, Marjorie Vermeersch, Pierre Van Antwerpen, Karim Amighi, Nathalie Wauthoz	121
13	Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy 2017 ·Scientific Reports ·Matthias Van Woensel, Thomas Mathivet, Nathalie Wauthoz, Rémi Rosière, Abhishek D. Garg, Patrizia Agostinis, Véronique Mathieu, Róbert Kiss, Florence Lefranc, Louis Boon, Jochen Belmans, Stefaan Van Gool, Holger Gerhardt, Karim Amighi, Steven De Vleeschouwer	114
14	Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration 2016 ·Journal of Controlled Release ·Matthias Van Woensel, Nathalie Wauthoz, Rémi Rosière, Véronique Mathieu, Róbert Kiss, Florence Lefranc, Brecht Steelant, Ellen Dilissen, Stefaan W. Van Gool, Thomas Mathivet, Holger Gerhardt, Karim Amighi, Steven De Vleeschouwer	133
15	Development of controlled-release cisplatin dry powders for inhalation against lung cancers 2016 ·International Journal of Pharmaceutics ·(unknown), Rémi Rosière, (unknown), Luca Fusaro, Gilles Berger, Karim Amighi, Nathalie Wauthoz	48
16	Platinum pharmacokinetics in mice following inhalation of cisplatin dry powders with different release and lung retention properties 2016 ·International Journal of Pharmaceutics ·(unknown), (unknown), Rémi Rosière, Karim Amighi, Nathalie Wauthoz	21
17	Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy 2016 ·International Journal of Pharmaceutics ·Rémi Rosière, Matthias Van Woensel, Véronique Mathieu, Ingrid Langer, Thomas Mathivet, Marjorie Vermeersch, Karim Amighi, Nathalie Wauthoz	34
18	New dry powders for inhalation containing temozolomide-based nanomicelles for improved lung cancer therapy 2015 ·International Journal of Oncology ·Rémi Rosière, Michel Gelbcke, Véronique Mathieu, Pierre Van Antwerpen, Karim Amighi, Nathalie Wauthoz	19
19	New Co-Spray-Dried Tobramycin Nanoparticles-Clarithromycin Inhaled Powder Systems for Lung Infection Therapy in Cystic Fibrosis Patients 2013 ·Journal of Pharmaceutical Sciences ·Gabrielle Pilcer, Rémi Rosière, Karl Traina, Thami Sebti, Francis Vanderbist, Karim Amighi	38
20	Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM? 2013 ·Cancers ·Matthias Van Woensel, Nathalie Wauthoz, Rémi Rosière, Karim Amighi, Véronique Mathieu, Florence Lefranc, Stefaan Van Gool, Steven De Vleeschouwer	127

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact